0
Skip to Content
WCNDD
Home
Overview
Leadership
Latest News
Warren Center Lecture Series
Areas of Focus
Discovery Teams
Pipeline
Publications
Collaborators
Get Involved
Contact
Support
WCNDD
Home
Overview
Leadership
Latest News
Warren Center Lecture Series
Areas of Focus
Discovery Teams
Pipeline
Publications
Collaborators
Get Involved
Contact
Support
Home
Folder: About
Back
Overview
Leadership
Latest News
Warren Center Lecture Series
Folder: Research
Back
Areas of Focus
Discovery Teams
Pipeline
Publications
Collaborators
Get Involved
Contact
Support

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-898

Oct 29
Written by Guest User
Full Press Release →
Guest User
Previous
Previous

Second schizophrenia treatment discovered at Vanderbilt’s Warren Center enters Phase I clinical trial
Next
Next

Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study of M4 Positive Allosteric Modulator NMRA-861
Newsletter Block
This newsletter signup form needs a storage option. Edit the block and enter a storage location via the Storage tab.

Stay Connected

Receive current news and updates about WCNDD when you sign up for our newsletter!

Thank you!

About | Careers | News | Contact | Privacy Policy

support scientific discovery →

© 2025 Vanderbilt University. All rights reserved. Vanderbilt, Vanderbilt University, and the Vanderbilt and WCNDD logos are trademarks of The Vanderbilt University.

615-875-9770

wcndd@vanderbilt.edu